2009-1552 Screening compound: N'-[(E)-[2-(benzyloxy)-5-bromophenyl]methylidene]-2-[2-(pyridin-2-yl)-1H-1,3-benzodiazol-1-yl]acetohydrazide

2009-1552 Screening compound: N'-[(E)-[2-(benzyloxy)-5-bromophenyl]methylidene]-2-[2-(pyridin-2-yl)-1H-1,3-benzodiazol-1-yl]acetohydrazide
2009-1552 Screening compound: N'-[(E)-[2-(benzyloxy)-5-bromophenyl]methylidene]-2-[2-(pyridin-2-yl)-1H-1,3-benzodiazol-1-yl]acetohydrazide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2009-1552
N'-[(E)-[2-(benzyloxy)-5-bromophenyl]methylidene]-2-[2-(pyridin-2-yl)-1H-1,3-benzodiazol-1-yl]acetohydrazide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2009-1552

Molecular Formula

C28H22BrN5O2 (C28 H22 BrN5 O2)

Compound Name

N'-[(E)-[2-(benzyloxy)-5-bromophenyl]methylidene]-2-[2-(pyridin-2-yl)-1H-1,3-benzodiazol-1-yl]acetohydrazide

IUPAC name

N'-[(E)-[2-(benzyloxy)-5-bromophenyl]methylidene]-2-[2-(pyridin-2-yl)-1H-13-benzodiazol-1-yl]acetohydrazide

SMILES

O=C(Cn1c(-c2ncccc2)nc2c1cccc2)N/N=C/c(cc(cc1)Br)c1OCc1ccccc1

InChI

InChI=1S/C28H22BrN5O2/c29-22-13-14-26(36-19-20-8-2-1-3-9-20)21(16-22)17-31-33-27(35)18-34-25-12-5-4-10-23(25)32-28(34)24-11-6-7-15-30-24/h1-17H,18-19H2,(H,33,35)

InChI Key

ALHCZOGFZCTWGB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01532636

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

540.42

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

6.157

Distribution Coefficient, logD

6.156

Water Solubility, LogSw

-5.93

Polar Surface Area

61.631

Acid Dissociation Constant (pKa)

10.00

Base Dissociation Constant (pKb)

3.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

7.10

2009-1552 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 2009-1552 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2009-1552?
Check Price and Availability of 2009-1552, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2009-1552 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2009-1552
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2009-1552
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2009-1552 available by request